Literature DB >> 12761673

Epidemiology of herpes simplex virus types 1 and 2 in Germany: what has changed?

S Buxbaum1, M Geers, G Gross, H Schöfer, H F Rabenau, H W Doerr.   

Abstract

Infections with herpes simplex virus (HSV) types 1 and 2 are widespread in all human populations and result in persistent and latent infections. HSV-1 is commonly responsible for orofacial, HSV-2 more likely causes genital lesions. Herpes genitalis is one of the most important sexually transmitted diseases; furthermore, there are severe diseases associated with HSV (e.g., encephalitis). Over the last years an increase in clinical manifestations of HSV has been reported, and HSV-1 has been increasingly discussed as causative agent of herpes genitalis. We retrospectively evaluated the laboratory results of our routine diagnostic service for HSV infections, looking for changes of HSV epidemiology in recent years. Specimens from 2,678 herpes patients were obtained between 1 January 1996 and 31 March 2002. Using cell culture, the presence of HSV was investigated in swabs taken from different body sites, and clinical data on HSV localization and type were evaluated. We found 345 patients positive for HSV-1 and 212 positive for HSV-2. Clinical data were available from 72.1% of the patients with HSV-1, and 61.3% of those with HSV-2 infection. In genital herpes HSV-1 was the causative agent in 20% of men and in 25% of women. In patients suffering from orofacial herpes HSV-2 was detected in 7% of men and in 4% of women. To evaluate the frequency of neurological HSV diseases, 2,406 cerebrospinal fluid samples (CSF) from 2,121 patients suspected of meningitis or encephalitis were tested for HSV DNA by the polymerase chain reaction. Among those patients, 120 showed CSF positive for HSV DNA. Serum surveys of HSV-1 and HSV-2 infection recently established in our region were compared to similar studies performed in Germany 25 years ago. We found that seroprevalences have not changed over the last 25 years and that neurological HSV diseases are rare. However, as in the USA, a significant percentage of herpes genitalis is caused by HSV-1 in Germany.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12761673     DOI: 10.1007/s00430-003-0183-0

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  19 in total

1.  Difference in seroprevalence of herpes simplex virus type 2 infection among antenatal women in Hong Kong and southern China.

Authors:  J Y Lo; W W Lim; D W Ho; P R Field; A L Cunningham
Journal:  Sex Transm Infect       Date:  1999-04       Impact factor: 3.519

2.  Herpes simplex virus type 2 in the United States, 1976 to 1994.

Authors:  D T Fleming; G M McQuillan; R E Johnson; A J Nahmias; S O Aral; F K Lee; M E St Louis
Journal:  N Engl J Med       Date:  1997-10-16       Impact factor: 91.245

3.  Enhancing effect of centrifugation on isolation of influenza virus from clinical specimens.

Authors:  M Seno; Y Kanamoto; S Takao; N Takei; S Fukuda; H Umisa
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

4.  Non-invasive diagnosis of herpes simplex encephalitis.

Authors:  K F Powell; N E Anderson; R W Frith; M C Croxson
Journal:  Lancet       Date:  1990-02-10       Impact factor: 79.321

5.  Seroprevalence of herpes simplex virus types 1 and type 2 in the Frankfurt am Main area, Germany.

Authors:  H F Rabenau; S Buxbaum; W Preiser; B Weber; H W Doerr
Journal:  Med Microbiol Immunol       Date:  2002-03       Impact factor: 3.402

6.  Prevalence of antibodies to herpes simplex virus in pregnant women in Stockholm in 1969, 1983 and 1989: implications for STD epidemiology.

Authors:  M Forsgren; E Skoog; S Jeansson; S Olofsson; J Giesecke
Journal:  Int J STD AIDS       Date:  1994 Mar-Apr       Impact factor: 1.359

7.  Seroprevalence study of herpes simplex virus type 2 among pregnant women in Germany using a type-specific enzyme immunoassay.

Authors:  G Enders; B Risse; M Zauke; I Bolley; F Knotek
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-12       Impact factor: 3.267

8.  Seroprevalence of herpes simplex virus type 2 antibodies in New Zealand sexual health clinic patients.

Authors:  N L Perkins; E P Coughlan; R A Franklin; M R Reid; J Taylor
Journal:  N Z Med J       Date:  1996-10-25

9.  Simple mathematical deductions in the seroepidemiology of viral infections. I. Herpesvirus group (herpesvirus hominis, varicella-zoster virus, cytomegalovris, Epstein-Barr-Virus).

Authors:  H W Doerr; H Lehmair; H Schmitz; D Kampa; T Luthardt
Journal:  Zentralbl Bakteriol Orig A       Date:  1977-06

Review 10.  Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review.

Authors:  Jennifer S Smith; N Jamie Robinson
Journal:  J Infect Dis       Date:  2002-10-15       Impact factor: 5.226

View more
  20 in total

Review 1.  Preventing vertical virus infections: the role of serologic screening of pregnant women.

Authors:  Annemarie Berger; Hans Wilhelm Doerr
Journal:  Med Microbiol Immunol       Date:  2018-07-03       Impact factor: 3.402

2.  Efficacy results of a trial of a herpes simplex vaccine.

Authors:  Robert B Belshe; Peter A Leone; David I Bernstein; Anna Wald; Myron J Levin; Jack T Stapleton; Iris Gorfinkel; Rhoda L Ashley Morrow; Marian G Ewell; Abbie Stokes-Riner; Gary Dubin; Thomas C Heineman; Joann M Schulte; Carolyn D Deal
Journal:  N Engl J Med       Date:  2012-01-05       Impact factor: 91.245

Review 3.  [Diagnosis and therapy of genitoanal ulcers of infectious etiology].

Authors:  B Malisiewicz; H Schöfer
Journal:  Hautarzt       Date:  2015-01       Impact factor: 0.751

4.  Fatal outcome of herpes simplex virus type 1-induced necrotic hepatitis in a neonate.

Authors:  Astrid Meerbach; Andreas Sauerbrei; Werner Meerbach; Hans-Jörg Bittrich; Peter Wutzler
Journal:  Med Microbiol Immunol       Date:  2006-01-11       Impact factor: 3.402

5.  Low prevalence of varicella zoster virus and herpes simplex virus type 2 in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy.

Authors:  Chunmei C Wang; Luis C Yepes; Robert J Danaher; Joseph R Berger; Yunanan Mootoor; Richard J Kryscio; Craig S Miller
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2010-02

6.  Herpes simplex virus type 1 is the leading cause of genital herpes in New Brunswick.

Authors:  Richard Garceau; Danielle Leblanc; Louise Thibault; Gabriel Girouard; Manon Mallet
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

7.  2-[4,5-Difluoro-2-(2-fluorobenzoylamino)-benzoylamino]benzoic acid, an antiviral compound with activity against acyclovir-resistant isolates of herpes simplex virus types 1 and 2.

Authors:  Mårten Strand; Koushikul Islam; Karin Edlund; Christopher T Oberg; Annika Allard; Tomas Bergström; Ya-Fang Mei; Mikael Elofsson; Göran Wadell
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

Review 8.  [Herpes simplex virus infections].

Authors:  G Gross
Journal:  Hautarzt       Date:  2004-09       Impact factor: 0.751

9.  Epidemiology of human cytomegalovirus (HCMV) in an urban region of Germany: what has changed?

Authors:  Paul R Lübeck; Hans Wilhelm Doerr; Holger F Rabenau
Journal:  Med Microbiol Immunol       Date:  2009-12-01       Impact factor: 3.402

Review 10.  [Genital herpes and HSV transmission in HIV patients].

Authors:  H F Rabenau; H W Doerr
Journal:  Hautarzt       Date:  2008-01       Impact factor: 0.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.